Arcadia Biosciences, Inc. (RKDA) News

Arcadia Biosciences, Inc. (RKDA): $2.66

0.05 (+1.92%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RKDA to Watchlist
Sign Up

Industry: Agriculture


Ranked

of 29

in industry

Filter RKDA News Items

RKDA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest RKDA News From Around the Web

Below are the latest news stories about Arcadia Biosciences Inc that investors may wish to consider to help them evaluate RKDA as an investment opportunity.

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

So what did the stock market do today?

Sarah Smith on InvestorPlace | April 26, 2021

RKDA: Arcadia Biosciences is Well Funded for Management’s 2021 Growth Initiatives in GoodWheat & GoodHemp; Also a Review of 2020 Achievements

By Steven Ralston, CFA NASDAQ:RKDA READ THE FULL RKDA RESEARCH REPORT Arcadia Biosciences (NASDAQ:RKDA) is on the cusp of meaningful revenue growth, primarily from management’s initiative into the hemp space, but also from the restructured strategic relationship with Bioceres Crop Solutions for the commercialization of HB4 soybean technology in the Central and South America. Furthermore, the

Yahoo | April 14, 2021

What's Happening With RKDA Stock Today?

Arcadia Biosciences Inc (NASDAQ: RKDA ) shares soared past … Full story available on Benzinga.com

Benzinga | March 31, 2021

34 Stocks Moving in Wednesday's Pre-Market Session

Gainers Arcadia Biosciences, Inc. (NASDAQ: RKDA ) rose 52% to $3.54 in pre-market trading after the company announced better-than-expected Q4 sales. ClearOne, Inc. (NASDAQ: CLRO ) rose 29.9% to $4.00 in pre-market trading. ClearOne shares fell over 6% on Tuesday after the company reported Q4 earnings results. X Financial (NYSE: XYF ) rose 20% to $4.02 in pre-market trading after gaining around 10% on Tuesday. Hywin Holdings Ltd. (NASDAQ: HYW ) shares rose 16.5% to $11.40 in pre-market trading. The company, last week, priced its IPO at $10 per ADS. CASI Pharmaceuticals, Inc. (NASDAQ: CASI ) rose 15.1% to $2.29 in pre-market trading. The company, on Tuesday, reported FY20 results.. ProPhase Labs, Inc. (NASDAQ: PRPH ) rose 14.5% to $7.18 in pre-market trading after the company disclosed th...

Benzinga | March 31, 2021

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2020 Financial Results and Business Highlights

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today released its financial and business results for the fourth quarter and full year of 2020.

Yahoo | March 30, 2021

Arcadia Biosciences, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 30, 2021 / Arcadia Biosciences, Inc. (NASDAQ:RKDA) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 30, 2021 at 4:30 PM Eastern Time.

Yahoo | March 30, 2021

Preview: Arcadia Biosciences's Earnings

On Tuesday, March 30, Arcadia Biosciences (NASDAQ:RKDA) will release its latest earnings report. Decipher the announcement with Benzinga's help. What Are Earnings, Net Income, And Earnings Per Share? Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding. Earnings And Revenue Arcadia Biosciences's per-share loss will be near $0.41 on sales of $1.26 million, according to Wall Street analysts. Arcadia Biosciences EPS in the same period a year ago totaled $0.72. Sales were $416.00 thousand. What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter? Analysts who cov...

Yahoo | March 29, 2021

Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2020 Financial Results and Business Highlights Conference Call

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional content of crops, today announced that it will release its 2020 fourth-quarter and full-year financial and business results after market close on March 30, 2021.

Yahoo | March 23, 2021

Arcadia Biosciences (RKDA) Expands GoodWheat™ Patent Portfolio

DAVIS, Calif., March 4, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced that the U.S. Patent and Trademark Office has awarded the company a…

PR Newswire | March 4, 2021

Arcadia Biosciences (RKDA) to Present at H.C. Wainwright's Global Life Sciences Conference March 9-10, 2021

DAVIS, Calif., March 2, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, announced today that it will be presenting at the H.C. Wainwright Global Life Sciences…

PR Newswire | March 2, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6718 seconds.